CWD
ABBV icon

Clarity Wealth Development’s AbbVie ABBV Stock Holding History

Clarity Wealth Development’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
+926
New +$199K 0.13% 52
2026
Q1 		– Sell
-997
Closed -$228K – 45
2025
Q4 		$228K Hold
997
– – 0.19% 41
2025
Q3 		$227K Sell
997
-115
-10% -$23.4K 0.2% 42
2025
Q2 		$206K Sell
1,112
-66
-6% -$12.3K 0.21% 43
2025
Q1 		$230K Sell
1,178
-8
-0.7% -$1.55K 0.26% 38
2024
Q4 		$218K Buy
+1,186
New +$218K 0.24% 42

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Clarity Wealth Development's ABBV Position: Q2 2026 in Review

Clarity Wealth Development opened a new position in AbbVie (ABBV) in Q2 2026: 926 shares worth $233K. The stake represents 0.13% of the portfolio and ranks #52 among its holdings. This is a return to the name: Clarity Wealth Development previously reported a position in ABBV as recently as Q4 2025.

Clarity Wealth Development first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Clarity Wealth Development held 926 shares of AbbVie worth $233K as of Q2 2026.
  • AbbVie was a new Clarity Wealth Development position in Q2 2026.
  • AbbVie made up 0.13% of Clarity Wealth Development's portfolio in Q2 2026, its #52 holding.
  • Clarity Wealth Development first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clarity Wealth Development's 13F filing for Q2 2026, filed 27 Jul 2026.